Wongvibulsin, Shannon
Martin, Seth S.
Steinhubl, Steven R.
Muse, Evan D.
Article History
First Online: 18 May 2019
Compliance with Ethical Standards
:
: Shannon Wongvibulsin, Steven R. Steinhubl, and Evan D. Muse each declare no potential conflicts of interest.Seth S. Martin serves on the scientific advisory boards of Amgen, Sanofi, Regeneron, Esperion, Novo Nordisk, Quest Diagnostics, and Akcea Therapeutics and reports grants from Apple, Google, iHealth, Nokia, Maryland Innovation Initiative, American Heart Association, Aetna Foundation, P J Schafer Memorial Fund, and David and June Trone Family Foundation. Dr. Martin reports a patent pending filed by Johns Hopkins as a co-inventor for a method of LDL-C estimation. Dr. Martin is a founder of and holds equity in Corrie Health, which intends to further develop the platform. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
: This article does not contain any studies with human or animal subjects performed by any of the authors.